# Finasteride side effects: mood and sexual health

Understand the difference between trial findings and postmarketing reports when weighing finasteride’s sexual and mood-related side effects.

Canonical: https://velri.co/blog/finasteride-mood-sexual-side-effect-worry-hairline-provider-conversation
Publisher: Velri (https://velri.co/about)
Published: 2026-07-24
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

Sexual side effects are a recognized risk of oral finasteride. Depression and suicidal thoughts or behavior also appear in FDA prescribing information, in the section covering reports received after approval. These findings come from different kinds of evidence and should not be folded into one risk percentage. [1]

## What the trials measured

In the first year of the hair-loss trials summarized in the label, sexual side effects included lower libido, erectile difficulties and ejaculation problems. One or more of these events was reported by 3.8% of men receiving finasteride and 2.1% receiving placebo. [1]

Those are group results from specific trials. They help put the possibility into context, but they do not predict whether an individual will have a side effect. The label also cautions that trial rates may differ from rates in routine practice. [1]

## What postmarketing reports add

The label includes reports of sexual dysfunction that continued after discontinuation, as well as depression and suicidal thoughts or behavior. Because they are voluntary and the size of the exposed population is uncertain, they cannot reliably establish how frequent those outcomes are or prove causation in every case. [1]

A scalp formulation does not remove every systemic concern. In 2025, the FDA warned about adverse events reported with compounded topical finasteride and noted that bloodstream absorption is expected. Compounded topical finasteride is not FDA approved. [2]

## Making the decision less abstract

Before treatment, it is reasonable to describe what your mood and sexual function are like now, what concerns would change your decision, and how follow-up would work. A later change is easier to explain when there is a clear starting point.

During treatment, useful information includes the exact symptom, when it began, its effect on daily life and the product being used. The conversation should address both how much the hair benefit matters to you and whether the symptoms make the treatment unacceptable.

New depression or major mood changes warrant prompt attention. Suicidal thoughts need immediate support: in the United States, call or text 988; call 911 for an immediate life-threatening emergency. [3]

## Sources
[1] PROPECIA (finasteride) tablets: prescribing information (2022). https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf
[2] FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products | FDA (2025). https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-consumers-potential-risks-associated-compounded
[3] Frequently Asked Questions About Suicide - National Institute of Mental Health (NIMH) (2025). https://www.nimh.nih.gov/health/publications/suicide-faq

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support